FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis
A. Justet (Paris, France), M. Ghanem (Paris, France), M. Jaillet (Paris, France), M. Hachem (Paris, France), T. Boghanim (Paris, France), A. Vadel (Paris, France), A. Mailleux (Paris, France), B. Crestani (Paris, France)
Source: Virtual Congress 2020 – Translational therapeutic advances
Session: Translational therapeutic advances
Session type: E-poster session
Number: 3359
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Justet (Paris, France), M. Ghanem (Paris, France), M. Jaillet (Paris, France), M. Hachem (Paris, France), T. Boghanim (Paris, France), A. Vadel (Paris, France), A. Mailleux (Paris, France), B. Crestani (Paris, France). FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis. 3359
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: